ABSTRACT
INTRODUCTION
Matrix-assisted laser desorption/ ionization time-of-flight (MALDI-TOF) mass spectrometry (4) has fast become one of the most widely applied techniques for the molecular weight determination of peptides and proteins. Soon after its introduction it was shown that high-accuracy analyses were possible using linear time-of-flight mass analyzers (2) . The mass determination process involved the incorporation of internal standards (of nominally the same molecular weight as the analyte) into the MALDI preparation; the signals of the internal standards are then used to calibrate the mass spectrum. Additionally, the weight-averaged centroids of the ion signals, rather than the peak apexes, were used in the determination. As demonstrated, the molecular weight of proteins in the 20-kDa mass range could be determined with accuracies of approximately ±2 Da. Although this order of accuracy (0.01%) is sufficient to recognize mass differences in proteins because of the addition or subtraction of functional groups (such as post-translational modifications and protecting groups), certain variations in protein structure, namely point mutations in sequence, can result in mass differences of as little as 1 Da. The 0.01% mass accuracy would therefore restrict the direct recognition of such small mass differences to proteins with molecular weights of less than 10 kDa.
Obviously, limitations in mass accuracy can be overcome using higher-performance instruments, and indeed, such instrumentation exists (reflectrongeometry and delayed-ion extraction TOF analyzers and Fourier transform ion cyclotron resonance mass spectrometers). However, even with improved mass accuracy, these instruments reach their greatest performance, again, in the sub-10-kDa mass range. It is therefore common, using both lowand high-performance instruments, to evaluate point mutations in proteins by using a process of "mass mapping" in which a protein is digested enzymatically, and the resulting (low molecular weight) proteolytic fragments are simultaneously mass-analyzed using MALDI-TOF. Limited digestions producing multiple, overlapping fragments are generally preferred over complete proteolysis. The reasoning here is quite simply that any given residue of a protein will be over-determined by the number of fragments (present in the mass spectrum) containing the residue; a process that is statistically preferred to sampling each residue of the protein only once.
A practical consideration during mass mapping is that limited proteolysis will always result in fragment-to-intact analyte ratios of less than one. That is, limited digestion of 1 pmol of analyte will always result in less than 1 pmol of a given fragment. Along these lines, sample can be lost to reaction vessel and pipettor walls during transfer and handling steps. Invariably, sample losses and the less than unity conversion of analyte-to-fragments results in a decrease in the overall sensitivity of the mass mapping. Another practical concern during mass mapping is the observance of autolysis fragments in the mass spectrum when too high an enzyme concentration is used. Although autolysis products can be identified through blank analysis of the enzyme solution, they (the autolysis signals) do represent an interference in the mass spectrum, which at worst can overwhelm signals due to the analyte. The adverse effects collectively due to sample losses in transfer and autolysis have been minimized by using enzymatically derivatized mass spectrometer probes (termed bioreactive probes) (3). These are conceptually simple devices that serve the twofold purpose of being both the enzymatic reagent and the probe for sample introduction into the mass spectrometer. Previous uses of the bioreactive probes include the mass mapping and partial sequencing of proteins (5) and "footprinting" proteins to recognize conformational differences (6) . These analyses were performed without the benefit of internally calibrating the mass spectra, and as a result, they have exhibited mass accuracies on the order of approximately 0.05% or less. This degree of accuracy translates to a 1-Da mass difference being discernible in species with molecular weights of <2 kDa. Presented here are methods utilizing bioreactive probes and linear MALDI-TOF mass spectrometry for the rapid, sensitive and accurate evaluation of point deviations, resulting in a mass difference of <0.01% of the molecular weight of the analyte protein.
MATERIALS AND METHODS

Preparation of Trypsin-Activated Gold Probes (Au/trypsin)
Bioreactive mass spectrometer probe tips were constructed essentially as previously described (3) with the exception of using gold-coated mass spectrometer probes rather than gold foil. Briefly, mass spectrometer probes (2.5-mm diameter) were vacuum sputter-coated with approximately 1000 nm Sho r t Technical Repo r t s of gold. The probe tips were then incubated for 30 min with dithiobis[succinimidylpropionate] (DSP; Pierce Chemical, Rockford, IL, USA) as a saturated solution in isopropanol. The cross-linking solution was decanted, and the probe tips rinsed repetitively with isopropanol, followed by rinses with ethanol. The probe tips were allowed to thoroughly dry and were incubated overnight at 4°C with an amount of NTosyl-L -phenylalanine chloromethyl ketone (TPCK)-treated trypsin (Sigma Chemical, St. Louis, MO, USA) solution (0.1 mg/mL in 20 mM phoshate buffer, pH 8.0) equal to approximately 200 µ L/probe tip. Following incubation, the probe tips were rinsed twice with phosphate buffer containing 0.1% Triton ® X-100 and approximately 10 mg/mL bovine serum albumin (BSA; Sigma Chemical) and twice with phosphate buffer. The probe tips were then allowed to thoroughly air-dry. In practice, active-probe tips were prepared in bulk (25-50 at a time) and stored at room temperature until needed.
Protein Digestion/Sample Preparation/Mass Spectrometry
Digestions were performed by applying 2.5 µ L of horse heart myoglobin (Sigma Chemical) (1 pmol/ µ L in 20 mM phosphate buffer, pH 8.0, 20 mM n-octyl pyranoglucoside) directly to the probe. The tips were allowed to stand in a humidified environment, maintained at a temperature of 60°C for 3 min before digestion was terminated by addition of the MALDI matrix, α -cyano-4-hydroxycinnamic acid (prepared as a saturated solution in a solvent mixture of 2:1, 1.3% aqueous trifluoroacetic acid:acetonitrile). Samples were allowed to air-dry before insertion into the mass spectrometer. Positive-ion mass spectrometry was performed using a linear TOF mass spectrometer (30 kV continuous ionextraction; 1.4 meter flight distance) that has been described in detail previously (6).
Mass Mapping
Mass spectra were internally calibrated using the average chemical molecular weights calculated for the singly or doubly protonated calibration a The listed fragment number corresponds to the fragment numbers shown in Figure 1 . b Amino acid residue numbers, inclusive. c Fragment molecular weights (in daltons) calculated from the "normal" myoglobin sequence. d Molecular weights determined from mass spectrum shown in Figure 1 , in daltons. e Fragment molecular weights (in daltons) calculated from the N122D myoglobin sequence. (m/z) 1/2 ] were generated by linear regression of data. The molecular weights of the analytical tryptic fragments were determined using the weight-averaged centroid of the upper 50% of the ion signals. Data were analyzed using the Rockefeller/New York University collaborative software available over the Internet (7) . Downloadable protein analysis worksheet software (PAWS) (1) was used in data evaluation.
RESULTS
Point mutations are recognized during mass mapping by the systematic mass-shift of select sets of ion signals in the mass spectrum; the signals within the set are due to proteolytic fragments containing the deviation. For highest analytical accuracy, the absolute masses of these signals must be determined with a degree of accuracy greater than the mass shift of the deviation (a process requiring the internal calibration of the mass spectrum). If the sequence of the analyte is one of a limited number of possibilities, a practical approach to calibrating the mass spectrum is to use the signals of the intact analyte as internal calibrants (singlestandard calibration). Alternatively, certain signals in the mass map will not contain the disputed amino acid residue and can therefore serve as internal calibrants (multiple-standard calibration). These calibration processes have been used to determine which of the two possible sequences listed in the SWISS-PROT database for horse heart myoglobin is correct. The two sequences differ at a single point, residue 122 being either asparagine ("normal") or aspartic acid (N122D), i.e.: Figure 1A shows the MALDI-TOF mass spectrum resulting from the 3-min digestion of 2.5 pmol of horse heart myoglobin using a trypsin-active probe. Ion signals are observed for approximately 35 tryptic fragments (with masses above 1 kDa). Although this number represents only approximately 15% of the 210 possible digest fragments, all but three of the possible trypsin-cleavage sites are represented in the mass spectrum. The mass spectral data (the 20 highest-intensity signals) were evaluated using a calibration equation generated from the singly and doubly charged ion signals of the intact myoglobin. By necessity, the procedure was performed twice, using the calculated molecular weight of either the "normal" myoglobin or the N122D variant. In both cases, the molecular weights of the tryptic fragments were determined to within 0.1 Da. This process created two datasets for use in comparison with the molecular weights calculated for potential tryptic fragments. 
Single-Standard Calibration
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approximately the same magnitude, are observed in both of the datasets for tryptic fragments 1-8 and fragment 20; these fragments do not contain the disputed residue. However, a difference is observed between the two datasets when evaluating tryptic fragments that contain the disputed residue. The dataset obtained using the "normal" myoglobin sequence (mol wt = 16 950.4 Da) shows a negative average mass shift for fragments 9-19, whereas the dataset obtained using the N122D sequence variant shows a positive average mass shift. Further, the difference in errors between fragments not containing and those containing residue 122 is greater for the "normal" myoglobin sequence (1.8 --0.07 = ca. 1.9 Da) than for the N122D variant (1.4 -0.54 = ca. 0.9 Da). These observations are consistent with the myoglobin containing the N122D point deviation.
Multiple-Standard Calibration
A second, more accurate method for the evaluation of point deviations is to use the ion signals of a number of digest fragments as internal calibrants; these are calibration fragments that do not contain the disputed residue (and are therefore equivalent regardless of the protein variant). This approach to calibration is attractive due not only to the use of multiple calibrants, but because the calibration signals are intermixed with the analytical signals. Figure 1B shows the multiple-standard calibration approach applied to ion signals in the 2000-10 000 Da mass range. Seven calibration signals (not containing residue 122) are available for use in the evaluation of eight analytical fragments (containing residue 122). Table 2 shows the results of using the multiplepoint calibration process in the evaluation of residue 122. The data again show the lowest degree of error for the N122D variant of the myoglobin.
DISCUSSION
Common to mass maps generated using the bioreactive probes is the significant over-sampling of each of the amino acids in the analyte. For instance, each amino acid of the myoglobin is analyzed at least six times during the mass mapping shown in Figure 1 , with the residue in question (residue 122) sampled at least eleven times. As such, both of the aforementioned ana - Table 2. lytical methods take advantage of the fact the mass mapping data will be internally consistent given the correct sequence of the protein, i.e., all mass values will fall into a single, low-error data set given the correct sequence of the analyte. Conversely, empirically derived data applied to an incorrect sequence will split the data into subsets of different errors. This is why the sign (positive or negative) of the errors are of equal importance as the magnitude of the errors. For instance, a sign-dependent average relative error was observed during comparison of the molecular weights determined for residue 122-containing fragments with the molecular weights calculated for the N122D version of the myoglobin (0.010% without sign; -0.006% considering sign). This observation is consistent with random error, the same type of error found upon re-evaluation of the calibration signals (average relative errors of 0.005% without sign; +0.002% considering sign). By contrast, the magnitude of the error observed when comparing the molecular weights of residue 122-containing fragments with the corresponding fragments of the "normal" myoglobin remained the same regardless of the sign convention (0.021% without sign; -0.021% with sign). The magnitude of the error being independent of sign convention is an indication of systematic error, which is the type of error expected with the assignment of empirical data to an incorrect sequence.
In closing, it is worth contrasting the above methods with a previous mass spectrometric study addressing the N122D discrepancy in myoglobin sequence. The investigations used liquidsecondary ion mass spectrometry/mass spectrometry to analyze tryptic fragments of horse heart myoglobin. Select tryptic fragments containing residue 122 were analyzed after fractionation/ isolation using reverse-phase HPLC (8) . Although the study was able to absolutely ascertain the identity of residue 122 as Asp (through the use of tandem mass spectrometry), the experiments were both involved (requiring >3 h to perform-the time of tryptic digest) and of low sensitivity (ca. 2 nmol of sample were introduced into the mass spectrometer). The analyses presented here, while reaching the same conclusion, required low picomole amounts of sample and were performed in minutes.
